https://www.businesswire.com/news/home/20260521195975/en/BeOne-Medicines-Sets-the-Pace-in-Oncology-at-ASCO-and-EHA-2026-with-60-Abstracts
BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that more than 60 abstracts across hematologic malig...
sets the pacebeone medicinesoncologyascoeha
https://myhematologia.pt/uncategorized/jose-maria-pons-assume-a-lideranca-da-beone-medicines-em-portugal-e-espanha/
José María Pons assume a liderança da BeOne Medicines em Portugal e Espanha - My Hematologia
Sep 16, 2026 - A BeOne Medicines, empresa global especializada em Oncologia, anuncia a nomeação de José María Pons como o novo diretor-geral para a Península Ibérica. Com...
beone medicinesponsassumeportugalespanha
https://hrportugal.sapo.pt/beone-medicines-tem-novo-director-geral/
BeOne Medicines tem novo director-geral - Human Resources
Sep 17, 2026 - A BeOne Medicines, empresa global de cancro, anuncia a nomeação de José María Pons como o novo director-geral para a Península Ibérica.
beone medicineshuman resourcestemnovodirector
https://lifesciencetracker.com/entries/beone-medicines-5-27-2025/
BeOne Medicines - 5/27/2025 - Incubate Investment Tracker
Jul 29, 2026 - We are a company built to address the long-lived challenges to return on investment in the pharmaceutical industry. Clinical trials represent more than 75% of...
beone medicinesincubateinvestmenttracker
https://hannibal.marketminute.com/article/bizwire-2025-6-2-beone-medicines-unveils-promising-clinical-data-for-two-novel-breast-cancer-therapies-at-asco-2025
BeOne Medicines Unveils Promising Clinical Data for Two Novel Breast Cancer Therapies at ASCO 2025...
BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, announced new clinical data from its emerging breast cancer pipeline...
beone medicinesfor twobreast cancerunveilspromising
https://www.businesswire.com/news/home/20260818126011/en/BeOne-Medicines-BeOne-Care-Foundation-and-The-Max-Foundation-Renew-Partnership-to-Expand-Access-to-BRUKINSA-for-the-Treatment-of-Chronic-Lymphocytic-Leukemia-in-Low--and-Middle-Income-Countries
BeOne Medicines, BeOne Care Foundation, and The Max Foundation Renew Partnership to Expand Access...
BeOne Medicines Ltd. (“BeOne”) (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, together with the BeOne Care Foundation, a nonprofit chari...
beone medicinesthe maxcarefoundationrenew
https://10xinsights.com/company/beone-medicines-ltd-onc
BeOne Medicines Ltd. (ONC) · 10x Insights
BeOne Medicines Ltd. is a global oncology company engaged in discovering, developing, and commercializing innovative cancer treatments designed to be more…
beone medicinesltdoncinsights
https://www.businesswire.com/news/home/20260831627298/ar
BeOne Medicines تعلن عن بيانات جديدة من المرحلة الثالثة حول معدلات البقاء على قيد الحياة، تعزّز...
أعلنت BeOne Medicines Ltd. (المدرجة في بورصة ناسداك بالرمز: ONC؛ وبورصة هونج كونج: 06160؛ وبورصة شنغهاي: 688235)، وهي شركة عالمية متخصصة في مجال علاج الأورام...
beone medicines
https://www.beonemedicines.com.cn/stories/cancer-has-no-borders-neither-do-we/
Cancer Has No Borders. Neither Do We. | BeOne Medicines
no bordersbeone medicinescancerneither
https://beonemedicines.ch/de/
Revolutionierung der Krebsbehandlung | BeOne Medicines
Mar 11, 2026 - BeOne Medicines hat sich der Entwicklung innovativer Medikamente gegen Krebs verschrieben und arbeitet mit der globalen Gemeinschaft zusammen, um Patienten auf...
beone medicinesder